LLYELI LILLY & CoSEC EDGAR
Use with Claude or ChatGPT

ELI LILLY & Co (LLY) Overview

Healthcare • NYSE • CIK 0000059478

Loading...

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Market Cap
$1.35T
P/E (TTM)
48.8x
Rev Growth (TTM)
+45.5%
Net Margin (TTM)
31.9%
FCF Yield (TTM)
1.5%
FCF Margin (TTM)
22.7%
Figures as of September 30, 2026
Data coverage notes

Operating income: no tagged operating-income figure (OperatingIncomeLoss) resolved for the trailing twelve months, so MetricDuck computes revenue minus total costs and expenses as it totals them; it is not a figure the filing tags as operating income. Operating margin, interest coverage, ROIC and EV/EBIT are built on it; no EBIT is synthesised.

Filings

Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.

10-Q2026 Q32026-10-29source
8-KEarnings2026-10-29source
10-Q2026 Q22026-08-05source
8-KEarnings2026-08-05source
8-KMay 20262026-05-20source
What your agent reads

Investor Relations

investor.lilly.com/financial-information/quarterly-results

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

Company-published, not SEC-audited

Earnings

Q3
18 days ago
8-K release
Revenue
$24.40B
+39.0%
Net Income
$6.45B
+16.0%
EPS
$7.22
+16.0%
Earnings call2025 Q4· machine-transcribedtranscript
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$19.7B
Q3 '26
$8.2B+6%
Q2 '26
$7.8B+158%
FCF Margin
TTM22.7%
Q3 '2633.7%
Sector: 3.0%Top 25%
OCF Margin
35.4%
OCF/NI1.11x
CapEx Coverage
2.8x
FCF Yield1.5%
FCF Growth (3Y)+81%
Cash Conversion Cycle
329 days
DSO: 80+DIO: 389−DPO: 139
Factsheet →
Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder YieldTTM
TTM0.9%
Div Yield0.5%
+
Buyback (TTM)0.4%
Dividend & Payout Metrics
Dividend Yield (TTM)0.5%
FCF Payout Ratio32.0%
Free Cash Flow (TTM)$19.7B
Stock Repurchases (TTM)$5.8B
Capital Return / FCF60.1%
Shares Outstanding (YoY)-0.5%↓ Buyback
Est. Dividends Paid (TTM)$6.3B
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
48.8x
Volatile
8Q: 39.0x-1285%
Valuation Lenses
Earnings
48.8x
vs – sector
Cash Flow
70.7x
EV/FCF vs –
Growth-Adj
1.0xPEG
Undervalued for growth
Quality-Adj
1.1P/E per %ROIC
ROIC: 45.3%
Shareholder Returns
Dividend
0.5%
Buyback
0.4%
Total Yield
0.9%
Market Cap$1.35T
EV$1.39T

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Multi-angle valuation analysis with sector context

Margins & Efficiency

ROIC 75th pctile
Profitability Cascade
Gross
83.6%
Operating
51.3%
Top 25% in sector
Net
31.9%
Margins Unknown
Return on Invested CapitalTTM
45.3%
Stable
+0.1% YoY8Q: 42.7%+8.1%
P25MedianP75
75th pctl (med: -6.9%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
40.7%
8Q: 37.6%
Asset Turnover
0.69x
8Q: 0.68x
Leverage (1+D/E)
2.23x
D/E: 1.23x
DuPont: 62.3% ≈ 45.3% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.21x
8Q:3.22x
+10.8%
Invested Cap Turn
1.34x
8Q:1.38x
-16.8%
CapEx Intensity
17.1%
8Q:16.8%
CapEx/Depreciation
5.05x
FCF vs Net Margin Gap-9.2 pts
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA 0.8x
Net Debt / EBITDA
0.8xNet Debt: $44.54B
Interest Coverage
34.7x
+Strong interest coverage: 34.7x
Leverage Metrics
Debt-to-Equity
1.23x
Balance sheet risk & solvency analysis

Related Research

3 related posts